Elevated Alpha Fetoprotein, No Hepatocellular Carcinoma

Sangiovanni, 2006, The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients, Hepatology, 43, 1303, 10.1002/hep.21176 European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer, 2012, EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol, 56, 908, 10.1016/j.jhep.2011.12.001 Gupta, 2003, Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis, Ann Intern Med, 139, 46, 10.7326/0003-4819-139-1-200307010-00012 Soresi, 2003, Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma, Anticancer Res, 23, 1747 Daniele, 2004, Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma, Gastroenterology, 127, S108, 10.1053/j.gastro.2004.09.023 Zhou, 2006, Serum tumor markers for detection of hepatocellular carcinoma, World J Gastroenterol, 12, 1175, 10.3748/wjg.v12.i8.1175 Yao, 2003, Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis, J Clin Gastroenterol, 36, 440, 10.1097/00004836-200305000-00017 Bae, 2005, Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma, Korean J Intern Med, 20, 80, 10.3904/kjim.2005.20.1.80